老澳门六合彩图库

header-logo
GettyImages-609179959-hero

Heart Failure Clinical Trials

Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy

The purpose of the study is to test the use of a drug called bromocriptine for women who have a condition called “Peripartum cardiomyopathy” or PPCM. PPCM means you have a weak heart after giving birth. The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill.

Principal Investigator: Sarah Thordsen, MD
Primary Study Coordinator: Shelley Schultz, CRC III

Status: Currently enrolling
Sub-Category: Advanced Heart Failure
ClinicalTrials.gov Identifier: NCT05180773

Meet Our Team

Cardiovascular Clinical Trials

The Cardiovascular Research Service is currently conducting drug and/or device trials in the cardiac subspecialties listed. However, this does not limit what we may be working on tomorrow.

Please contact the Cardiovascular Trials program by calling (414) 955-6784 or at DOMCVClinTriStaff@mcw.edu.